2022 Fall Conference | C7 - Neuromyelitis Optica Spectrum Disorders

��ɫ��

2022 Fall Conference | C7 - Neuromyelitis Optica Spectrum Disorders

Date Friday 10/28/22

Time 01:00 PM - 02:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Amy T. Waldman, MD

Topic(s) Multiple Sclerosis, Autoimmune Neurology

Learning Objectives Participants should be able to describe clinical presentation of NMOSD; discuss diagnostic criteria for NMOSD; compare and contrast clinical features of NMOSD with common diseases that mimic NMOSD; be familiar with the imaging characteristics of NMOSD; and discuss approved treatment options for NMOSD.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Program Materials

Event Timeline
01:00 PM - 02:30 PM PDT	Speaker	Neuromyelitis Optica Spectrum Disorders Amy T. Waldman, MD

Faculty Disclosures
Amy T. Waldman, MD	Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care.

��ɫ����

��ɫ����

��ɫ��

��ɫ��